Evidence map›Paper›PMID 34815494›Full record

ArticleScientific reports2021

Novel non intrusive continuous use ZeBox technology to trap and kill airborne microbes.

Kruttika S Phadke, Deepak G Madival, Janani Venkataraman, Debosmita Kundu, K S Ramanujan, Nisha Holla, Jaywant Arakeri, Gaurav Tomar, Santanu Datta, Arindam Ghatak

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Kruttika S PhadkeBiomoneta Research Private Limited, Bangalore, 560065, India.
Deepak G MadivalBiomoneta Research Private Limited, Bangalore, 560065, India.
Janani VenkataramanBiomoneta Research Private Limited, Bangalore, 560065, India.
Debosmita KunduBiomoneta Research Private Limited, Bangalore, 560065, India.
K S RamanujanBiomoneta Research Private Limited, Bangalore, 560065, India.
Nisha HollaBiomoneta Research Private Limited, Bangalore, 560065, India.
Jaywant ArakeriMechanical Engineering Department, Indian Institute of Science, Bangalore, 560012, India.
Gaurav TomarMechanical Engineering Department, Indian Institute of Science, Bangalore, 560012, India.
Santanu DattaBiomoneta Research Private Limited, Bangalore, 560065, India.
Arindam GhatakBiomoneta Research Private Limited, Bangalore, 560065, India. arindam@biomoneta.com.
Indian Institute of Science Bangalore · INCellworks Research (India) · INIowa State University · US

Funding

COVID-19 Consortium BT/COVID0025/01/20Department of Biotechnology- Biotechnology Industry Research Assistance Council (DBT-BIRAC), Govt. of India BT/SBIRI1372/31/16
6 · The paper itself

Abstract

Preventing nosocomial infection is a major unmet need of our times. Existing air decontamination technologies suffer from demerits such as toxicity of exposure, species specificity, noxious gas emission, environment-dependent performance and high power consumption. Here, we present a novel technology called "ZeBox" that transcends the conventional limitations and achieves high microbicidal efficiency. In ZeBox, a non-ionizing electric field extracts naturally charged microbes from flowing air and deposits them on engineered microbicidal surfaces. The surface's three dimensional topography traps the microbes long enough for them to be inactivated. The electric field and chemical surfaces synergistically achieve rapid inactivation of a broad spectrum of microbes. ZeBox achieved near complete kill of airborne microbes in challenge tests (5-9 log reduction) and [Formula: see text] efficiency in a fully functional stem cell research facility in the presence of humans. Thus, ZeBox fulfills the dire need for a real-time, continuous, safe, trap-and-kill air decontamination technology.

Indexed as

Air FiltersAir MicrobiologyAir Pollution, IndoorAnti-Infective AgentsCross InfectionDecontaminationHumansParticulate MatterTechnologyAnti-Infective AgentsParticulate Matter

Identifiers

PMID34815494
PMCPMC8610990
OpenAlexW3216051432

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.